Dennis Hom

Dennis Hom

Former Chief Financial OfficeratSagimet Biosciences· In proxies 2022–2023

Pay in FY2023+60% from the year before

Dennis Hom was paid $745.5K in FY2023 (Dec), up 60%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Sagimet Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Sagimet BiosciencesPublic company · 4 yr
    • Former Chief Financial Officer2022 – Present · 4 yrStock in role -33%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?